Updated:
Enclara Pharmacia
Enclara Pharmacia is a pharmacy benefit management company based in Philadelphia, United States. It specializes in pharmacy benefit management for hospice and...
Enclara Pharmacia
Enclara Pharmacia is a pharmacy benefit management company based in Philadelphia, United States. It specializes in pharmacy benefit management for hospice and palliative care. The company has not disclosed any total funding.
General information
Firm type
other
Location
Region
North America
Country
United States
City
Philadelphia
Corporate office
1601 Cherry Street Suite 1800 Philadelphia, PA 19102, United States
Additional offices
Tennessee
Principals
Sherin Kuruvilla
PharmD.
Josh Paire
Vice President of Pharmacy Operations
Sector focus
Frequently asked questions
Who runs investment decisions at Enclara Pharmacia?
Enclara Pharmacia is not an investment manager — it is a pharmacy solutions provider for hospice care. The company's leadership includes a corporate management team; VP of Pharmacy Operations Josh Paire oversees fulfillment operations. No CIO or investment committee is identified on the public website.
What investment stages does Enclara typically target?
Enclara does not target investment stages. It is a pharmacy services company, not an investment firm. No venture, private equity, or fund commitments are disclosed on its website.
Which sectors does Enclara explicitly avoid?
Enclara only serves the hospice and palliative care community. It does not serve general healthcare, retail customers, or other segments.
How is Enclara related to Dragonfly Health?
Enclara is a Dragonfly Health company (per firm website). Dragonfly Health offers combined pharmacy, DME, and service solutions nationally. The relationship is parent-subsidiary, though Enclara operates as a distinct brand focused on hospice pharmacy.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: